Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-Contrast-Enhanced Breast MRI in the Evaluation of Newly Diagnosed Breast Cancer: A Pilot Study

NCT: NCT07874256 · NOT_YET_RECRUITING

NCT IDNCT07874256
StatusNOT_YET_RECRUITING
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

This pilot study is evaluating whether breast MRI without contrast dye can provide useful information in patients who have recently been diagnosed with breast cancer. The study uses MRI techniques to look at breast tissue and the extent of cancer without an intravenous gadolinium injection and compare it to contrast enhanced MRI.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑